Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholecystectomy, Laparoscopic | 17 | 2022 | 34 | 3.940 |
Why?
|
| Cholecystitis, Acute | 7 | 2022 | 7 | 2.170 |
Why?
|
| Cholecystectomy | 8 | 2021 | 17 | 1.940 |
Why?
|
| Laparoscopy | 13 | 2022 | 171 | 1.770 |
Why?
|
| Bile Ducts | 8 | 2021 | 11 | 1.400 |
Why?
|
| Gallstones | 3 | 2022 | 9 | 1.340 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2022 | 1 | 0.820 |
Why?
|
| Practice Guidelines as Topic | 6 | 2018 | 344 | 0.750 |
Why?
|
| Postoperative Complications | 17 | 2018 | 991 | 0.700 |
Why?
|
| Bile Duct Diseases | 4 | 2021 | 5 | 0.670 |
Why?
|
| Cholangitis | 5 | 2018 | 5 | 0.620 |
Why?
|
| Pancreatic Neoplasms | 8 | 2013 | 155 | 0.570 |
Why?
|
| Humans | 66 | 2022 | 30994 | 0.560 |
Why?
|
| General Surgery | 4 | 2014 | 58 | 0.550 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 3 | 2018 | 8 | 0.530 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 1133 | 0.520 |
Why?
|
| Endosonography | 3 | 2017 | 11 | 0.520 |
Why?
|
| Gallbladder Diseases | 1 | 2015 | 5 | 0.520 |
Why?
|
| Intraoperative Complications | 4 | 2020 | 75 | 0.510 |
Why?
|
| Mesothelioma, Cystic | 1 | 2014 | 1 | 0.480 |
Why?
|
| Peritoneal Neoplasms | 1 | 2014 | 6 | 0.480 |
Why?
|
| Cysts | 3 | 2008 | 16 | 0.460 |
Why?
|
| Cholecystitis | 1 | 2013 | 10 | 0.450 |
Why?
|
| Kidney Diseases | 1 | 2014 | 125 | 0.430 |
Why?
|
| Kidney | 1 | 2014 | 181 | 0.430 |
Why?
|
| Quality Improvement | 4 | 2014 | 165 | 0.420 |
Why?
|
| Ultrasonography | 4 | 2022 | 271 | 0.390 |
Why?
|
| Female | 40 | 2018 | 16980 | 0.390 |
Why?
|
| Male | 37 | 2018 | 16442 | 0.390 |
Why?
|
| Adult | 22 | 2018 | 8929 | 0.360 |
Why?
|
| Colectomy | 3 | 2016 | 23 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2018 | 817 | 0.350 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2008 | 23 | 0.350 |
Why?
|
| Iatrogenic Disease | 2 | 2020 | 28 | 0.320 |
Why?
|
| Pancreatic Cyst | 2 | 2008 | 3 | 0.320 |
Why?
|
| Middle Aged | 28 | 2018 | 10192 | 0.310 |
Why?
|
| Treatment Outcome | 13 | 2018 | 3806 | 0.310 |
Why?
|
| Adenocarcinoma | 6 | 2005 | 206 | 0.310 |
Why?
|
| Multimodal Imaging | 2 | 2018 | 22 | 0.300 |
Why?
|
| Video Recording | 2 | 2018 | 44 | 0.300 |
Why?
|
| Length of Stay | 4 | 2018 | 339 | 0.280 |
Why?
|
| Endoscopy | 2 | 2021 | 199 | 0.280 |
Why?
|
| Pancreatectomy | 3 | 2003 | 13 | 0.270 |
Why?
|
| Image-Guided Biopsy | 2 | 2018 | 31 | 0.270 |
Why?
|
| Liver | 3 | 2017 | 184 | 0.270 |
Why?
|
| Retrospective Studies | 13 | 2018 | 3656 | 0.260 |
Why?
|
| Fellowships and Scholarships | 1 | 2006 | 45 | 0.260 |
Why?
|
| Aged | 23 | 2018 | 10045 | 0.250 |
Why?
|
| Surgeons | 3 | 2021 | 87 | 0.250 |
Why?
|
| Internship and Residency | 4 | 2014 | 227 | 0.250 |
Why?
|
| United States | 9 | 2021 | 2375 | 0.240 |
Why?
|
| Drainage | 4 | 2017 | 52 | 0.230 |
Why?
|
| Colonic Neoplasms | 2 | 2016 | 74 | 0.230 |
Why?
|
| Biopsy | 2 | 2014 | 249 | 0.230 |
Why?
|
| Tokyo | 6 | 2018 | 6 | 0.230 |
Why?
|
| Ganglioneuroma | 2 | 2003 | 6 | 0.210 |
Why?
|
| Surveys and Questionnaires | 4 | 2021 | 1210 | 0.200 |
Why?
|
| Neuroblastoma | 1 | 2002 | 20 | 0.200 |
Why?
|
| Neoplasms, Second Primary | 1 | 2002 | 36 | 0.190 |
Why?
|
| Stomach Neoplasms | 4 | 2015 | 32 | 0.190 |
Why?
|
| Aged, 80 and over | 8 | 2018 | 5189 | 0.180 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 1991 | 93 | 0.180 |
Why?
|
| Blood Loss, Surgical | 2 | 2018 | 67 | 0.180 |
Why?
|
| Operative Time | 2 | 2018 | 85 | 0.180 |
Why?
|
| Prospective Studies | 7 | 2018 | 1898 | 0.180 |
Why?
|
| Societies, Medical | 1 | 2021 | 191 | 0.180 |
Why?
|
| Education, Medical, Graduate | 2 | 2014 | 88 | 0.170 |
Why?
|
| Hernia, Ventral | 2 | 2014 | 19 | 0.170 |
Why?
|
| Surgical Mesh | 2 | 2014 | 24 | 0.170 |
Why?
|
| Disease Management | 2 | 2017 | 126 | 0.170 |
Why?
|
| Pancreaticoduodenectomy | 3 | 2013 | 35 | 0.170 |
Why?
|
| Stents | 2 | 2017 | 85 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 407 | 0.170 |
Why?
|
| Safety | 2 | 2016 | 49 | 0.170 |
Why?
|
| Hernia, Inguinal | 2 | 1996 | 17 | 0.160 |
Why?
|
| Carcinoma | 2 | 2016 | 64 | 0.150 |
Why?
|
| Cholelithiasis | 3 | 1995 | 9 | 0.150 |
Why?
|
| Patient Admission | 1 | 2018 | 30 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2018 | 430 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 420 | 0.150 |
Why?
|
| Herniorrhaphy | 2 | 2014 | 31 | 0.150 |
Why?
|
| Lymph Nodes | 1 | 2018 | 74 | 0.150 |
Why?
|
| Survival Rate | 6 | 2018 | 403 | 0.150 |
Why?
|
| Hypertrophy | 1 | 2017 | 20 | 0.150 |
Why?
|
| Checklist | 1 | 2017 | 38 | 0.150 |
Why?
|
| Neovascularization, Physiologic | 1 | 2017 | 23 | 0.150 |
Why?
|
| Biliary Tract Diseases | 2 | 1994 | 4 | 0.140 |
Why?
|
| Liver Regeneration | 1 | 2017 | 23 | 0.140 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 90 | 0.140 |
Why?
|
| Acute Disease | 4 | 2018 | 231 | 0.140 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 1921 | 0.140 |
Why?
|
| Portal Vein | 1 | 2017 | 42 | 0.140 |
Why?
|
| Professional Practice | 1 | 1996 | 9 | 0.140 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2016 | 6 | 0.130 |
Why?
|
| Enterostomy | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gastrectomy | 2 | 2015 | 34 | 0.130 |
Why?
|
| Hypertension, Portal | 1 | 1995 | 1 | 0.130 |
Why?
|
| Ascites | 1 | 1995 | 5 | 0.130 |
Why?
|
| Blood Coagulation Disorders | 1 | 1995 | 15 | 0.130 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 61 | 0.130 |
Why?
|
| Algorithms | 1 | 2018 | 414 | 0.130 |
Why?
|
| Hospital Costs | 1 | 1996 | 68 | 0.120 |
Why?
|
| Clinical Competence | 2 | 2014 | 241 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2018 | 328 | 0.120 |
Why?
|
| Cholangiography | 5 | 2015 | 11 | 0.120 |
Why?
|
| Appendectomy | 1 | 2014 | 16 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2014 | 12 | 0.120 |
Why?
|
| Problem-Based Learning | 1 | 2014 | 7 | 0.120 |
Why?
|
| Liver Diseases | 1 | 1995 | 41 | 0.120 |
Why?
|
| Appendicitis | 1 | 2014 | 18 | 0.120 |
Why?
|
| Congenital Abnormalities | 1 | 2014 | 9 | 0.120 |
Why?
|
| Biliary Fistula | 2 | 2014 | 6 | 0.120 |
Why?
|
| Hernia, Hiatal | 1 | 2014 | 11 | 0.120 |
Why?
|
| Models, Educational | 1 | 2014 | 37 | 0.120 |
Why?
|
| Lymphoma | 1 | 2014 | 46 | 0.120 |
Why?
|
| Palliative Care | 1 | 1996 | 154 | 0.120 |
Why?
|
| Abdominal Pain | 2 | 1991 | 10 | 0.120 |
Why?
|
| Risk Assessment | 3 | 2018 | 718 | 0.120 |
Why?
|
| Intestine, Small | 2 | 2014 | 34 | 0.120 |
Why?
|
| Duodenal Neoplasms | 2 | 2013 | 9 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2015 | 135 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 2 | 1995 | 46 | 0.120 |
Why?
|
| Hemobilia | 1 | 2014 | 1 | 0.120 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 1 | 0.120 |
Why?
|
| Mirizzi Syndrome | 1 | 2014 | 1 | 0.120 |
Why?
|
| Cutaneous Fistula | 1 | 2014 | 3 | 0.120 |
Why?
|
| Ileus | 1 | 2014 | 3 | 0.120 |
Why?
|
| Urinary Fistula | 1 | 2014 | 3 | 0.120 |
Why?
|
| Duodenal Diseases | 1 | 2014 | 6 | 0.120 |
Why?
|
| Vascular Fistula | 1 | 2014 | 4 | 0.120 |
Why?
|
| Intestinal Fistula | 1 | 2014 | 7 | 0.120 |
Why?
|
| Credentialing | 1 | 2014 | 8 | 0.110 |
Why?
|
| Elective Surgical Procedures | 1 | 2014 | 43 | 0.110 |
Why?
|
| Prognosis | 7 | 2018 | 918 | 0.110 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2013 | 39 | 0.110 |
Why?
|
| Biomarkers, Tumor | 1 | 2014 | 217 | 0.100 |
Why?
|
| Biliary Tract Neoplasms | 2 | 1991 | 3 | 0.100 |
Why?
|
| Lithotripsy | 1 | 1992 | 2 | 0.100 |
Why?
|
| Sepsis | 1 | 2014 | 154 | 0.100 |
Why?
|
| Physicians | 1 | 2014 | 119 | 0.100 |
Why?
|
| Young Adult | 1 | 2018 | 2063 | 0.100 |
Why?
|
| Appendiceal Neoplasms | 1 | 1991 | 5 | 0.100 |
Why?
|
| Sarcoma, Kaposi | 1 | 1991 | 5 | 0.100 |
Why?
|
| Opportunistic Infections | 1 | 1990 | 9 | 0.090 |
Why?
|
| Logistic Models | 3 | 2016 | 409 | 0.090 |
Why?
|
| Risk Factors | 4 | 2020 | 2586 | 0.090 |
Why?
|
| Recurrence | 3 | 2014 | 370 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2016 | 354 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2007 | 38 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2007 | 70 | 0.070 |
Why?
|
| Minimally Invasive Surgical Procedures | 2 | 2014 | 306 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2007 | 39 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1988 | 192 | 0.070 |
Why?
|
| Registries | 1 | 2007 | 201 | 0.070 |
Why?
|
| Carcinosarcoma | 1 | 2005 | 4 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 582 | 0.060 |
Why?
|
| Pancreas | 1 | 2005 | 37 | 0.060 |
Why?
|
| Contraindications | 2 | 1995 | 42 | 0.060 |
Why?
|
| Survival Analysis | 4 | 2015 | 320 | 0.060 |
Why?
|
| Sphincter of Oddi | 1 | 1984 | 1 | 0.060 |
Why?
|
| Ampulla of Vater | 1 | 1984 | 7 | 0.060 |
Why?
|
| Liver Neoplasms | 2 | 1997 | 121 | 0.060 |
Why?
|
| Morbidity | 2 | 2014 | 64 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2018 | 1311 | 0.060 |
Why?
|
| Intraoperative Period | 3 | 1997 | 33 | 0.060 |
Why?
|
| Polypropylenes | 1 | 2003 | 2 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2003 | 5 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2002 | 52 | 0.050 |
Why?
|
| Duodenum | 2 | 1994 | 10 | 0.050 |
Why?
|
| Hepatectomy | 2 | 2017 | 58 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 818 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 1992 | 386 | 0.040 |
Why?
|
| Anastomosis, Surgical | 2 | 2016 | 41 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2018 | 2 | 0.040 |
Why?
|
| Software Design | 1 | 2017 | 1 | 0.040 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2018 | 8 | 0.040 |
Why?
|
| Conversion to Open Surgery | 1 | 2017 | 3 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 15 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 1672 | 0.040 |
Why?
|
| Gallbladder | 1 | 2017 | 5 | 0.040 |
Why?
|
| Japan | 1 | 2017 | 11 | 0.040 |
Why?
|
| Korea | 1 | 2017 | 10 | 0.040 |
Why?
|
| Taiwan | 1 | 2017 | 14 | 0.040 |
Why?
|
| Conservative Treatment | 1 | 2017 | 14 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2017 | 30 | 0.040 |
Why?
|
| Early Diagnosis | 1 | 2018 | 69 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 43 | 0.040 |
Why?
|
| Liver Circulation | 1 | 2017 | 2 | 0.040 |
Why?
|
| Portal Pressure | 1 | 2017 | 2 | 0.040 |
Why?
|
| Ligation | 1 | 2017 | 33 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 105 | 0.040 |
Why?
|
| Swine | 1 | 2017 | 92 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2018 | 243 | 0.040 |
Why?
|
| Organ Size | 1 | 2017 | 107 | 0.040 |
Why?
|
| Community-Acquired Infections | 1 | 2018 | 82 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 146 | 0.040 |
Why?
|
| Laparotomy | 2 | 1997 | 29 | 0.040 |
Why?
|
| Patient Safety | 1 | 2017 | 53 | 0.040 |
Why?
|
| Consensus | 1 | 2017 | 112 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 2042 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 429 | 0.030 |
Why?
|
| Gastrostomy | 1 | 1996 | 8 | 0.030 |
Why?
|
| Jejunostomy | 1 | 1996 | 8 | 0.030 |
Why?
|
| Cost Savings | 1 | 1996 | 33 | 0.030 |
Why?
|
| Prothrombin Time | 1 | 1995 | 2 | 0.030 |
Why?
|
| Whole Blood Coagulation Time | 1 | 1995 | 4 | 0.030 |
Why?
|
| Platelet Count | 1 | 1995 | 22 | 0.030 |
Why?
|
| Hemostasis, Surgical | 1 | 1995 | 15 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 148 | 0.030 |
Why?
|
| Intestines | 1 | 2016 | 115 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 1995 | 31 | 0.030 |
Why?
|
| Neuroendocrine Tumors | 1 | 1995 | 23 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2017 | 507 | 0.030 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 1996 | 77 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 26 | 0.030 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1994 | 3 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 70 | 0.030 |
Why?
|
| Competitive Behavior | 1 | 2014 | 7 | 0.030 |
Why?
|
| Punctures | 1 | 1994 | 11 | 0.030 |
Why?
|
| Abdominal Injuries | 1 | 1994 | 4 | 0.030 |
Why?
|
| Hemoglobins | 1 | 1995 | 81 | 0.030 |
Why?
|
| Stomach | 1 | 1994 | 19 | 0.030 |
Why?
|
| Colonic Diseases | 1 | 2014 | 15 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 90 | 0.030 |
Why?
|
| Cholestasis | 1 | 1993 | 8 | 0.030 |
Why?
|
| Illinois | 1 | 2014 | 267 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2014 | 65 | 0.030 |
Why?
|
| Digestive System | 1 | 1993 | 16 | 0.030 |
Why?
|
| Wound Healing | 1 | 2014 | 174 | 0.030 |
Why?
|
| Animals | 2 | 2017 | 4722 | 0.030 |
Why?
|
| Puerto Rico | 1 | 1993 | 12 | 0.030 |
Why?
|
| Nervous System Neoplasms | 1 | 1992 | 4 | 0.030 |
Why?
|
| Endocrine Gland Neoplasms | 1 | 1992 | 3 | 0.030 |
Why?
|
| Reoperation | 3 | 2002 | 950 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2014 | 103 | 0.030 |
Why?
|
| Pancreatitis | 2 | 2003 | 25 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1993 | 46 | 0.030 |
Why?
|
| Data Collection | 1 | 1993 | 109 | 0.030 |
Why?
|
| Ursodeoxycholic Acid | 1 | 1992 | 5 | 0.030 |
Why?
|
| Colic | 1 | 1992 | 2 | 0.030 |
Why?
|
| Neurosecretory Systems | 1 | 1991 | 9 | 0.020 |
Why?
|
| Incidence | 1 | 1994 | 785 | 0.020 |
Why?
|
| Emergencies | 1 | 1990 | 40 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1987 | 14 | 0.020 |
Why?
|
| Bile Duct Neoplasms | 1 | 1986 | 8 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 549 | 0.020 |
Why?
|
| Common Bile Duct | 1 | 1986 | 2 | 0.020 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 1986 | 7 | 0.020 |
Why?
|
| Angiography | 1 | 1986 | 42 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1988 | 337 | 0.020 |
Why?
|
| Common Bile Duct Diseases | 1 | 1984 | 2 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 263 | 0.010 |
Why?
|
| Carcinoma, Acinar Cell | 1 | 2003 | 4 | 0.010 |
Why?
|
| Peritoneum | 1 | 2003 | 18 | 0.010 |
Why?
|
| Medical Records | 1 | 2002 | 34 | 0.010 |
Why?
|
| Ethanol | 1 | 1984 | 139 | 0.010 |
Why?
|
| Radiography | 2 | 1994 | 695 | 0.010 |
Why?
|
| Biomechanical Phenomena | 1 | 1984 | 698 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 532 | 0.010 |
Why?
|
| Age Factors | 2 | 1997 | 873 | 0.010 |
Why?
|
| Adolescent | 1 | 1986 | 2401 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 341 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1997 | 91 | 0.010 |
Why?
|
| Sex Factors | 1 | 1997 | 511 | 0.010 |
Why?
|
| Peptic Ulcer | 1 | 1994 | 6 | 0.010 |
Why?
|
| Digestive System Neoplasms | 1 | 1993 | 6 | 0.010 |
Why?
|
| Larynx | 1 | 1993 | 15 | 0.010 |
Why?
|
| Gastroplasty | 1 | 1994 | 22 | 0.010 |
Why?
|
| Pharynx | 1 | 1993 | 15 | 0.010 |
Why?
|
| Leiomyosarcoma | 1 | 1993 | 21 | 0.010 |
Why?
|
| Esophagus | 1 | 1993 | 74 | 0.010 |
Why?
|
| Contrast Media | 1 | 1994 | 136 | 0.010 |
Why?
|
| Gastric Bypass | 1 | 1994 | 66 | 0.010 |
Why?
|
| Immunologic Techniques | 1 | 1991 | 3 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1991 | 22 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1992 | 404 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1991 | 152 | 0.010 |
Why?
|
| Pancreatic Fistula | 1 | 1986 | 2 | 0.000 |
Why?
|
| Gastric Emptying | 1 | 1986 | 13 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1986 | 49 | 0.000 |
Why?
|